November 20, 2025
Ms. Duckworth (for herself, Mr. Hoeven, Mr. Durbin, and Mrs. Britt) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation
To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen and air traffic control specialists, and for other purposes.
Section 1. Short title
This Act may be cited as the Aviation Medication Transparency Act of 2025
.
Sec. 2. Aviation medication transparency; list of approved medications
(a) Purpose
The purpose of this Act is to ensure that aviation stakeholders, including airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists, who are applicants for medical certification are informed, in a user-friendly and accessible manner, of the medications they may be safely prescribed.
(b) In general
Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration (in this section referred to as the Administrator
) shall publish and maintain on a publicly available website of the Federal Aviation Administration (in this section referred to as the FAA
) a list of medications that the Administrator, as of the date of publication, has—
(1)
determined may be safely prescribed to an applicant for medical certification to treat certain medical conditions; and
(2)
approved for purposes of the issuance of a medical certification to an airman or air traffic control specialist.
(c) Requirements
To ensure medical appropriateness, user-friendliness, and appropriate dissemination, the list required under subsection (b) shall—
(1)
be drafted in consultation with—
(A)
the Aeromedical Innovation and Modernization Working Group (established under section 411(a) of the FAA Reauthorization Act of 2024 (49 U.S.C. 44703 note)) (in this section referred to as the Working Group
);
(B)
institutions of higher education that are accredited by the Aviation Accreditation Board International;
(C)
the certified exclusive bargaining representatives of air traffic controllers of the FAA certified under section 7111 of title 5, United States Code;
(D)
organizations representing certified collective bargaining representative of airline pilots; and
(E)
any other stakeholder determined relevant by the Working Group;
(2)
cover all medications approved by the Administrator, including prescription medications and over-the-counter medications;
(3)
be drafted in a user-friendly and accessible manner and provided to airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists at the time when any such individual first seeks a medical certification;
(4)
if applicable, indicate the minimum and average period of time an airman or air traffic control specialist is required to have limited or no duties to stabilize on an approved medication;
(5)
include the list of medications that the Administrator has designated as Do Not Issue
;
(6)
include information for doctors or medical providers to contact the FAA regarding questions related to such list, including through a new or existing mechanism that is accessible to such doctors and medical providers;
(7)
include any additional information that the Administrator determines is appropriate to provide with respect to what conditions a certain medication may or may not be used to treat, as well as any information to explain why a medication is allowed or prohibited by the FAA; and
(8)
include any other information or clarification that the Administrator determines appropriate.
(d) Annual update
Not later than 1 year after the date of publication of the list required under subsection (b), and annually thereafter, the Administrator shall update such list, as appropriate.